These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 17889375

  • 21. Immunopharmacology of CpG DNA.
    Dalpke A, Zimmermann S, Heeg K.
    Biol Chem; 2002 Oct; 383(10):1491-500. PubMed ID: 12452427
    [Abstract] [Full Text] [Related]

  • 22. Potentiation of TLR9 responses for human naïve B-cell growth through RP105 signaling.
    Yamazaki K, Yamazaki T, Taki S, Miyake K, Hayashi T, Ochs HD, Agematsu K.
    Clin Immunol; 2010 Apr; 135(1):125-36. PubMed ID: 20133206
    [Abstract] [Full Text] [Related]

  • 23. CpG DNA stimulates autoreactive immature B cells in the bone marrow.
    Azulay-Debby H, Edry E, Melamed D.
    Eur J Immunol; 2007 Jun; 37(6):1463-75. PubMed ID: 17474151
    [Abstract] [Full Text] [Related]

  • 24. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.
    Gäbele E, Mühlbauer M, Dorn C, Weiss TS, Froh M, Schnabl B, Wiest R, Schölmerich J, Obermeier F, Hellerbrand C.
    Biochem Biophys Res Commun; 2008 Nov 14; 376(2):271-6. PubMed ID: 18760996
    [Abstract] [Full Text] [Related]

  • 25. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
    Kennedy NJ, Spithill TW, Tennent J, Wood PR, Piedrafita D.
    Vaccine; 2006 Feb 13; 24(7):970-9. PubMed ID: 16242220
    [Abstract] [Full Text] [Related]

  • 26. Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice.
    Prater MR, Johnson VJ, Germolec DR, Luster MI, Holladay SD.
    Vaccine; 2006 Jan 16; 24(3):263-71. PubMed ID: 16143434
    [Abstract] [Full Text] [Related]

  • 27. TLR9 expression is related to immune activation but is impaired in individuals with chronic immune activation.
    Ayash-Rashkovsky M, Bentwich Z, Borkow G.
    Int J Biochem Cell Biol; 2005 Nov 16; 37(11):2380-94. PubMed ID: 16024265
    [Abstract] [Full Text] [Related]

  • 28. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
    Yu D, Putta MR, Bhagat L, Li Y, Zhu F, Wang D, Tang JX, Kandimalla ER, Agrawal S.
    J Med Chem; 2007 Dec 13; 50(25):6411-8. PubMed ID: 17988082
    [Abstract] [Full Text] [Related]

  • 29. Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern.
    Iliev ID, Kitazawa H, Shimosato T, Katoh S, Morita H, He F, Hosoda M, Saito T.
    Cell Microbiol; 2005 Mar 13; 7(3):403-14. PubMed ID: 15679843
    [Abstract] [Full Text] [Related]

  • 30. Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers.
    Borges O, Borchard G, de Sousa A, Junginger HE, Cordeiro-da-Silva A.
    Int J Pharm; 2007 Jun 07; 337(1-2):254-64. PubMed ID: 17317051
    [Abstract] [Full Text] [Related]

  • 31. Mechanisms of TLR9 activation.
    Latz E, Visintin A, Espevik T, Golenbock DT.
    J Endotoxin Res; 2004 Jun 07; 10(6):406-12. PubMed ID: 15588423
    [Abstract] [Full Text] [Related]

  • 32. The role of CpG dinucleotides in DNA vaccines.
    Krieg AM, Yi AK, Schorr J, Davis HL.
    Trends Microbiol; 1998 Jan 07; 6(1):23-7. PubMed ID: 9481820
    [Abstract] [Full Text] [Related]

  • 33. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL, Tang LF, Lew FC, Wong HS, Chua YL, MacAry PA, Kemeny DM.
    J Immunol; 2009 Jul 01; 183(1):41-50. PubMed ID: 19535645
    [Abstract] [Full Text] [Related]

  • 34. The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector.
    Pasquini S, Deng H, Reddy ST, Giles-Davis W, Ertl HC.
    Gene Ther; 1999 Aug 01; 6(8):1448-55. PubMed ID: 10467369
    [Abstract] [Full Text] [Related]

  • 35. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M.
    J Leukoc Biol; 2009 Aug 01; 86(2):261-71. PubMed ID: 19401392
    [Abstract] [Full Text] [Related]

  • 36. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells.
    Jiang W, Sun R, Zhou R, Wei H, Tian Z.
    J Immunol; 2009 Mar 15; 182(6):3768-74. PubMed ID: 19265155
    [Abstract] [Full Text] [Related]

  • 37. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.
    Chen Y, Lenert P, Weeratna R, McCluskie M, Wu T, Davis HL, Krieg AM.
    Gene Ther; 2001 Jul 15; 8(13):1024-32. PubMed ID: 11438837
    [Abstract] [Full Text] [Related]

  • 38. DNA methylation and TLR9 ligands: not only a matter of semantics.
    Baldari CT.
    Immunol Lett; 2008 Nov 16; 121(1):84-5. PubMed ID: 18805440
    [No Abstract] [Full Text] [Related]

  • 39. Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism.
    Anderson RB, Cianciolo GJ, Kennedy MN, Pizzo SV.
    J Leukoc Biol; 2008 Feb 16; 83(2):381-92. PubMed ID: 17967834
    [Abstract] [Full Text] [Related]

  • 40. Enhanced B-cell activation mediated by TLR4 and BCR crosstalk.
    Minguet S, Dopfer EP, Pollmer C, Freudenberg MA, Galanos C, Reth M, Huber M, Schamel WW.
    Eur J Immunol; 2008 Sep 16; 38(9):2475-87. PubMed ID: 18819072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.